Sunday, January 23, 2011

Teva and AstraZeneca's EP patent on Seroquel

Reuters reports: Israel's Teva Pharmaceutical Industries has launched a High Court action in London to revoke the European patent for Seroquel, an anti-depressant [used in cases of schizophrenia and bipolar] developed by AstraZeneca

The US Hatch-Waxman case over Seroquel (quetiapine) began in DNJ in 2005. See IPBiz post Teva makes paragraph IV filing against AstraZeneca over Seroquel


Post a Comment

<< Home